Genetic Study of Melanoma in Jewish Families
Author Information
Author(s): Marian C, Scope A, Laud K, Friedman E, Pavlotsky F, Yakobson E, Bressac-de Paillerets B, Azizi E
Primary Institution: Institut Gustave Roussy, Villejuif, France
Hypothesis
Are CDKN2A/ARF and CDK4 genes involved in the inherited predisposition to melanoma and associated neural system tumors in Jewish families?
Conclusion
In most Ashkenazi Jewish families, the CDKN2A/ARF and CDK4 genes are unlikely to be involved in the predisposition to melanoma and associated neural system tumors.
Supporting Evidence
- No germline alterations in CDKN2A/ARF and CDK4 were detected among the families studied.
- The only sequence variation identified was a polymorphism not associated with melanoma risk.
- Previous studies indicated that 20% of melanoma families have genetic alterations at the CDKN2A/ARF gene.
Takeaway
The study looked at Jewish families to see if certain genes caused melanoma and brain tumors, but they didn't find any harmful changes in those genes.
Methodology
The study involved genotyping families for mutations in the CDKN2A/ARF and CDK4 genes using various molecular techniques.
Limitations
The study did not screen for mutations in noncoding regions, which could also contribute to familial melanoma.
Participant Demographics
The study included 42 Jewish families, primarily of Ashkenazi origin.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website